PROCEPT BioRobotics Corporation

NASDAQ (USD): PROCEPT BioRobotics Corporation (PRCT)

Last Price

79.81

Today's Change

-2.18 (2.65%)

Day's Change

79.55 - 82.78

Trading Volume

573,361

Profile
PRCT

Exchange:  NASDAQ Global Market NASDAQ Global Market

Currency:  USD USD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Dr. Reza Zadno Ph.D. Dr. Reza Zadno Ph.D.

Full Time Employees:  626 626

IPO Date:  2021-09-15 2021-09-15

CIK:  0001588978 0001588978

ISIN:  US74276L1052 US74276L1052

CUSIP:  74276L105 74276L105

Beta:  1.03 1.03

Last Dividend:  0.00 0.00

Dcf Diff:  0.00 0.00

Dcf:  0.00 0.00

Description

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

Address

900 Island Drive,
Redwood City, CA 94065, US

650 232 7200

http://www.procept-biorobotics.com

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment